eClinical Solutions Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: eClinical Solutions Market covers analysis by Offerings {Software Solutions [Randomization & Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CLMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master File (eTMF), Electronic Data Capture, and Others] and Services}, Delivery Mode (On-Premise, Cloud Based, and Web Based), Therapeutic Area (Cardiovascular, Diabetes, Metabolic Diseases, Gastroenterology, COVID-19, Rare Disease, Precision Medicine, and Others), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), and End User (Contract Research Organizations, Medical Device Companies, Pharma/Biotech Companies, Hospitals & Clinics, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPHE100001161
  • Category : Healthcare IT
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

The eClinical solutions market is expected to grow from US$ 8,380.63 million in 2021 to US$ 20,476.11 million by 2028; it is expected to grow at a CAGR of 13.6% from 2022 to 2031.

eClinical solutions include software, platforms, and services that are essentially employed for the efficient management of clinical trials and clinical research development. The software of eClinical solutions assists in managing, maintaining, and recording data and tracking deadlines of various drug evolutions, among other features. It is useful in the treatment of various diseases and conditions, such as rare diseases, COVID-19, infectious diseases, cardiovascular diseases, and diabetes.

MARKET DYNAMICS

The small and large companies operating in the eClinical solutions market are adopting various strategies, including regional expansion and technological advancements, to increase their market share. The rising number of government grants coupled with a growing number of rare diseases has supported the growth of the eClinical solutions market in recent years; furthermore, it is expected to continue a similar trend during the forecast period. Moreover, the rising adoption of cloud based platforms by biopharmaceutical companies is anticipated to create lucrative opportunities for the market growth in the coming years.

MARKET SCOPE

The "Global eClinical Solutions Market Forecast to 2028" report aims to provide an overview of the market with detailed market segmentation on the basis of offerings, therapeutic areas, clinical trial phase, and end user. The report provides key statistics based on the financial performances of the leading market players. It also offers key trends and opportunities in the market.

Strategic Insights

MARKET SEGMENTATION

The global eClinical solutions market is segmented on the basis of offerings, delivery mode, therapeutic areas, clinical trial phase, and end user. Based on offerings, the market is bifurcated into software solutions and services. The software solutions segment is further segmented into randomization & trial supply management (RTSM), clinical data management system (CDMS), clinical trial management system (CLMS), electronic clinical outcome assessment (eCOA), electronic trial master file (eTMF), electronic data capture, and others. Based on delivery mode, the market is segmented into on-premise, cloud based, and web based. Based on therapeutic areas, the eClinical solutions market is categorized into cardiovascular, diabetes, metabolic diseases, gastroenterology, rare diseases, COVID-19, precision medicine, and others. Based on clinical trial phase, the market is segmented into phase I, phase II, phase III, and phase IV. Based on end user, the market is categorized into contract research organizations, medical device companies, pharma/biotech companies, hospitals & clinics, and others


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
REGIONAL FRAMEWORK

The global eClinical solutions market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. The report covers analysis and forecast of 18 countries globally along with trends and opportunities prevailing in all abovementioned regions.

North America dominates the eClinical solutions market. The North America eClinical solutions market is further segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021 and is expected to continue a similar trend during the forecast period. The rising cases of rare diseases in the region supported the growth of the eClinical solutions market. According to the FDA, in 2020, more than 30 million people were affected by 7,000 rare diseases affected in the US. As a result, biopharmaceutical and pharmaceutical companies in the region are adopting seamless clinical trial management approaches to mitigate the spread of rare diseases in a short duration and develop drugs that are helpful in the treatment of such diseases.

eClinical solutions market Source: The Insight Partners Analysis

The report analyses factors, such as drivers, restraints, opportunities, and future trends, which impact the growth of the eClinical solutions market. The report also provides PEST analysis, highlighting the factors affecting the eClinical solutions market in these regions.

IMPACT OF COVID-19 PANDEMIC

The COVID-19 pandemic has positively impacted the eClinical solutions market. In 2020 and 2021, the rising cases of COVID-19 cases in several developed and developing economies increased the adoption of eClinical solution options that assist the development of drugs in pharmaceutical companies. Numerous capital investments in the advancement of clinical assets are increasing the number of phase II and phase III clinical trials owing to the rising cases of COVID-19 in developing nations and its adverse impact on the overall economy.

World Geography
Strategic Insights

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

The report covers key developments in the eClinical solutions market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, patents, and events. In addition, the market is witnessing various inorganic growth strategies, including acquisitions, partnerships, and collaborations. These activities have encouraged the expansion of business and the customer base of market players. The players operating in the eClinical solutions market are anticipated to experience lucrative growth opportunities in the future, owing to the rising demand for eClinical solutions.

The report also includes the profiles of key companies operating in the eClinical solutions market, along with their SWOT analysis and market strategies. In addition, it focuses on leading industry players with information such as company profiles, components and services offered, financial information of the last three years, and key development in the past five years.

The list of a few companies engaged in the eClinical solutions market is mentioned below:

  • Clario
  • Merge Healthcare (IBM)
  • ALTEN Group
  • Signant Health
  • Oracle Corporation
  • Medidata Solutions
  • Parexel International Corporation
  • Bioclinica
  • Datatrak International
  • Revele
  • Other Market Participants

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Market Research

healthcare-it
Research Criteria
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Offerings, Delivery Mode, Therapeutic Area, Clinical Trial Phase, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. PAREXEL International Corporation.
2. Oracle
3. Medidata Solutions, Inc.
4. Bioclinica
5. DATATRAK Int.
6. ERT Clinical
7. CRF Health
8. OmniComm Systems, Inc.
9. Bio-Optronics, Inc.
10. IBM Watson Health

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to eClinical Solutions Market